Sharapova cautioned at least 5 times about Meldonium

Letters from two global tennis bodies had warned her in advance about the impending ban on the drug she'd been taking since 2006

Maria Sharapova
BS Web Teamagencies Mumbai
Last Updated : Mar 09 2016 | 9:28 PM IST
Russian tennis star, Maria Sharapova, had been cautioned about the impeding inclusion of meldonium in the World Anti-Doping Agency (WADA)'s list of banned drugs on at least five occasions before the ban was actually implemented.

The Times newspaper reported on Wednesday that the International Tennis Federation had sent the tenns player three letters informing her about WADA's decision to implement the ban from January 1 this year. Sharapova also received two letters on the same issue from the Women's Tennis Association.

Sharapova had confessed on Monday that she had tested positive for Meldonium, a drug she said she had been taking since 2006 but that was banned by WADA only this year.

Meanwhile, the Kremlin insisted that Sharapova's case was an isolated one even as it expressed regret over the discovery. A spokesperson of the agency insisted that the incident did not reflect Russian sports as a whole and should not be used to tarnish the image of Russian sportspersons in general

Sharapova claimed she began taking Meldonium to address a number of health  issues, such as being prone to illness, heart condition and a family history of diabetes.

 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 09 2016 | 9:22 PM IST

Next Story